Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
- PMID: 35493453
- PMCID: PMC9046566
- DOI: 10.3389/fimmu.2022.887648
Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
Keywords: chemotherapy; graft (regulation); graft versus host disease (GVHD); haploidentical hematopoietic stem cell transplantation; murine (mouse).
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
-
Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation.Front Immunol. 2022 Feb 15;13:796349. doi: 10.3389/fimmu.2022.796349. eCollection 2022. Front Immunol. 2022. PMID: 35242129 Free PMC article.
References
-
- Hadjis AD, Nunes NS, Khan SM, Fletcher RE, Pohl A, Venzon DJ, et al. Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation. Front Immunol (2022) 13:796349. doi: 10.3389/fimmu.2022.796349 - DOI - PMC - PubMed
-
- Routy B, Letendre C, Enot D, Chenard-Poirier M, Mehraj V, Seguin NC, et al. The Influence of Gut-Decontamination Prophylactic Antibiotics on Acute Graft-Versus-Host Disease and Survival Following Allogeneic Hematopoietic Stem Cell Transplantation. Oncoimmunology (2017) 6(1):e1258506. doi: 10.1080/2162402X.2016.1258506 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
